Skip to main content

Table 2 Quality measures of the plans presented as examples

From: A novel implementation of mARC treatment for non-dedicated planning systems using converted IMRT plans

Prostate patient

Measures of quality

Standard IMRT plan

Version a/b, 6 MV

Version c, 6 MV

PTV

D2 (Gy)

51.73

53.98

53.59

D50 (Gy)

50.60

51.62

51.45

D98 (Gy)

48.13

45.59

44.97

HI

0.07

0.16

0.17

Rectum

D2 (Gy)

50.60

51.05

50.55

D30 (Gy)

35.18

36.25

35.63

D50 (Gy)

24.94

21.61

19.93

Bladder

D2 (Gy)

51.28

52.69

52.63

D30 (Gy)

48.97

43.06

43.12

D50 (Gy)

34.50

14.69

13.57

Femoral head (right)

D2 (Gy)

32.99

37.43

34.50

D30 (Gy)

24.09

25.39

24.37

D50 (Gy)

20.49

18.46

18.13

Head-and-neck patient

Measures of quality

Standard IMRT plan

2 arcs FFF 7 MV (version c)

PTV

D2 (Gy)

54.47

53.32

D50 (Gy)

45.55

44.86

D98 (Gy)

50.55

50.67

HI

0.18

0.17

Right parotid

D2 (Gy)

7.30

5.41

D50 (Gy)

48.37

51.82

Dmean (Gy)

15.36

13.62

Spinal cord

D2 (Gy)

21.28

21.28

D50 (Gy)

25.36

25.25

Dmean (Gy)

19.77

19.30

  1. The values presented are based on the ICRU Report 83 [8]. The homogeneity index is defined as HI = (D2 – D98) / D50. We only give dose values for the right femoral head and right parotid, since they receive higher doses than their left counterparts.